Joy in Ageing Competition

Following on from the 2023 ‘Hope in Ageing’ poetry competition organised by the charity Embracing Age, 2024’s competition theme has been announced as ‘Joy in Ageing’.   The competition, which is open to anyone over 50, is inviting entries in various formats – poetry, art and multimedia.   The organisers say:    “We invite you to capture the … Read more

The Times Health Commission 10-point plan for the NHS

The Times Health Commission has published a 10-point plan and report that looks at health and social care in Britain today.  The commission, which was set up in January 2023, has been evidence-based and sought to learn the lessons from the best examples of health and care provision in the UK and abroad.   The authors … Read more

Forthcoming book from Emma Heming Willis

Bruce Willis’ wife, Emma, has announced plans to publish a book (currently untitled) in 2025 about her experiences as a carer to Bruce who lives with frontotemporal dementia.  Emma said of her experiences of her husband’s dementia diagnosis:  “For many people, their first touch point about this disease is received in their doctor’s office. I … Read more

Benefits of family intervention to support independence

A study published in The Lancet Healthy Longevity has shown that NIDUS-Family (New Interventions for Independence in Dementia Study) helps people with dementia and their family carers reach personal goals.    Participants worked with a facilitator to set their personal goals to live independently at home for as long as possible, and these were then mapped … Read more

Bob’s Brainwaves goes live to help families

Chris Suich, whose husband Bob has dementia, has created a kit to help carers and families affected by dementia.   The kit, Bob’s Brainwaves, includes ideas to support a person with dementia to live at home for longer, as well as important documents and forms. The local signposting that’s included is focused on Louth, Lincolnshire, alongside … Read more

Alzheimer’s drug aducanumab to be discontinued

It has been announced by pharmaceutical company, Biogen, that Alzheimer’s drug aducanumab (commercially known as Aduhelm) will be withdrawn from use by November 2024. Biogen say this isn’t due to any safety or efficacy concerns.  Aducanumab was offered to people living with Alzheimer’s in the US from June 2021, but was not approved for use … Read more

People with lived experience of dementia wanted for NIHR Policy Research Unit

The National Institute for Health and Care Research (NIHR) Policy Research Unit are looking for people with dementia (of any type) to join their Policy Research Unit to help shape their work.  Involvement opportunities are varied and participants are paid for their time.  You can find out more by contacting Rachael Litherland from Innovations in … Read more

ADI announces launch of AD-RIDDLE project

Alzheimer’s Disease International (ADI) has announced its participation in and launch of the AD-RIDDLE project.   The project is a collaboration between academics, healthcare providers, pharmaceutical and diagnostic companies, regulatory bodies and patient advocacy organisations. It aims to improve detection, diagnosis and prevention of Alzheimer’s disease and, whilst initially focused on European countries, it’s hoped it … Read more

Labour unveils new life sciences sector strategy

Labour has announced plans for a life sciences sector strategy, with an emphasis on clinical trial participation to help find new treatments for conditions including Alzheimer’s disease.   The plan would include establishing standing national registries for clinical trials, boosting public participation in clinical trials, and making better use of data.  You can find out more … Read more

Alzheimer’s Society Funding Rounds Open

The Alzheimer’s Society have opened their funding rounds for researchers to obtain grants.  You can find out more here https://alzheimers.org.uk/research/researchers/grants  and apply through the Alzheimer’s Society portal here: https://grants.alzheimers.org.uk  The deadline for applications is 22 March 2024.